{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:24:58Z","timestamp":1772637898321,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03133-4","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:19:13Z","timestamp":1748467153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mitigating Shear Stress in Spray Drying for RNA-Loaded Lipid Nanoparticles through Process and Formulation Optimization"],"prefix":"10.1208","volume":"26","author":[{"given":"Susana","family":"Farinha","sequence":"first","affiliation":[]},{"given":"Rute","family":"Mota","sequence":"additional","affiliation":[]},{"given":"Carolina","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Velez","sequence":"additional","affiliation":[]},{"given":"Mara G.","family":"Freire","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Aguiar-Ricardo","sequence":"additional","affiliation":[]},{"given":"Miguel \u00c2ngelo","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Joana S.","family":"Crist\u00f3v\u00e3o","sequence":"additional","affiliation":[]},{"given":"Paulo Roque","family":"Lino","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"3133_CR1","doi-asserted-by":"crossref","unstructured":"Arabi F, Mansouri V, Ahmadbeigi N. Gene therapy clinical trials, where do we go? An overview. Biomedicine & Pharmacotherapy. 2022;153:113324. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222007132.","DOI":"10.1016\/j.biopha.2022.113324"},{"key":"3133_CR2","doi-asserted-by":"publisher","unstructured":"Lopes C, Crist\u00f3v\u00e3o J, Silv\u00e9rio V, Lino PR, Fonte P. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications. Expert Opin Drug Deliv. 2022;19:1381\u201396. Available from: https:\/\/doi.org\/10.1080\/17425247.2022.2135502.","DOI":"10.1080\/17425247.2022.2135502"},{"key":"3133_CR3","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1080\/17425247.2022.2135502","volume":"19","author":"C Lopes","year":"2022","unstructured":"Lopes C, Crist\u00f3v\u00e3o J, Silv\u00e9rio V, Lino PR, Fonte P. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications. Expert Opin Drug Deliv. 2022;19:1381\u201396.","journal-title":"Expert Opin Drug Deliv"},{"key":"3133_CR4","unstructured":"European Medicines Agency. Assessment report: COVID-19 Vaccine Comirnaty. EMA\/707383\/2020 Corr1*. 2021;31:1\u2013140. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/comirnaty-epar-public-assessment-report_en.pdf."},{"key":"3133_CR5","doi-asserted-by":"crossref","unstructured":"Uddin MN, Roni MA. Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines. Vaccines (Basel). 2021;9:1033. Available from: https:\/\/www.mdpi.com\/2076-393X\/9\/9\/1033.","DOI":"10.3390\/vaccines9091033"},{"key":"3133_CR6","doi-asserted-by":"publisher","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharm. 2021;601:120586. Available from: https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120586.","DOI":"10.1016\/j.ijpharm.2021.120586"},{"key":"3133_CR7","doi-asserted-by":"publisher","unstructured":"Crommelin DJA, Anchordoquy TJ, Volkin DB, Jiskoot W, Mastrobattista E. Addressing the Cold Reality of mRNA Vaccine Stability. J Pharm Sci. 2020;110:997\u20131001. Available from: https:\/\/doi.org\/10.1016\/j.xphs.2020.12.006.","DOI":"10.1016\/j.xphs.2020.12.006"},{"key":"3133_CR8","doi-asserted-by":"crossref","unstructured":"Farinha S, S\u00e1 J V., Lino PR, Gal\u00e9sio M, Pires J, Rodrigues M\u00c2, et al. Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery. Pharm Res. 2023;40:1115\u201340. Available from: https:\/\/link.springer.com\/10.1007\/s11095-022-03442-4\n.","DOI":"10.1007\/s11095-022-03442-4"},{"key":"3133_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/10837450.2018.1507039","volume":"24","author":"B Daneshmand","year":"2019","unstructured":"Daneshmand B, Faghihi H, Amini Pouya M, Aghababaie S, Darabi M, Vatanara A. Application of disaccharides alone and in combination, for the improvement of stability and particle properties of spray-freeze dried IgG. Pharm Dev Technol. 2019;24:439\u201347.","journal-title":"Pharm Dev Technol"},{"key":"3133_CR10","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1208\/s12249-018-1023-2","volume":"19","author":"MA Pouya","year":"2018","unstructured":"Pouya MA, Daneshmand B, Aghababaie S, Faghihi H, Vatanara A. Spray-Freeze Drying: a Suitable Method for Aerosol Delivery of Antibodies in the Presence of Trehalose and Cyclodextrins. AAPS PharmSciTech. 2018;19:2247\u201354.","journal-title":"AAPS PharmSciTech"},{"key":"3133_CR11","doi-asserted-by":"crossref","unstructured":"Kommineni N, Butreddy A, Sainaga Jyothi VGS, Angsantikul P. Freeze-drying for the preservation of immunoengineering products. iScience. 2022;25:105127.","DOI":"10.1016\/j.isci.2022.105127"},{"key":"3133_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ddtec.2008.11.001","volume":"5","author":"MJ Maltesen","year":"2008","unstructured":"Maltesen MJ, van de Weert M. Drying methods for protein pharmaceuticals. Drug Discov Today Technol. 2008;5:81\u20138.","journal-title":"Drug Discov Today Technol"},{"key":"3133_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymthe.2022.02.001","volume":"30","author":"H Muramatsu","year":"2022","unstructured":"Muramatsu H, Lam K, Bajusz C, Laczk\u00f3 D, Karik\u00f3 K, Schreiner P, et al. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Mol Ther. 2022;30:1\u201311.","journal-title":"Mol Ther"},{"key":"3133_CR14","doi-asserted-by":"crossref","unstructured":"Malamatari M, Charisi A, Malamataris S, Kachrimanis K, Nikolakakis I. Spray drying for the preparation of nanoparticle-based drug formulations as dry powders for inhalation. Processes. 2020;8.","DOI":"10.3390\/pr8070788"},{"key":"3133_CR15","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.xphs.2019.01.011","volume":"108","author":"IB Sebasti\u00e3o","year":"2019","unstructured":"Sebasti\u00e3o IB, Bhatnagar B, Tchessalov S, Ohtake S, Plitzko M, Luy B, et al. Bulk Dynamic Spray Freeze-Drying Part 2: Model-Based Parametric Study for Spray-Freezing Process Characterization. J Pharm Sci. 2019;108:2075\u201385.","journal-title":"J Pharm Sci"},{"key":"3133_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejpb.2021.01.014","volume":"161","author":"C Marschall","year":"2021","unstructured":"Marschall C, Witt M, Hauptmeier B, Friess W. Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins. Eur J Pharm Biopharm. 2021;161:37\u201349.","journal-title":"Eur J Pharm Biopharm"},{"key":"3133_CR17","doi-asserted-by":"crossref","unstructured":"Donthi MR, Butreddy A, Saha RN, Kesharwani P, Dubey SK. Leveraging spray drying technique for advancing biologic product development\u2013A mini review. Health Sciences Review. 2024;10:100142. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772632023000685.","DOI":"10.1016\/j.hsr.2023.100142"},{"key":"3133_CR18","doi-asserted-by":"crossref","unstructured":"Friis KP, Gracin S, Oag S, Leijon A, Sand E, Lindberg B, et al. Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA. Journal of Controlled Release. 2023;363:389\u2013401. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37741463.","DOI":"10.1016\/j.jconrel.2023.09.031"},{"key":"3133_CR19","doi-asserted-by":"publisher","unstructured":"Sarode A, Patel P, Vargas-Montoya N, Allawzi A, Zhilin-Roth A, Karmakar S, et al. Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery. Drug Deliv Transl Res. 2023; Available from: https:\/\/doi.org\/10.1007\/s13346-023-01402-y.","DOI":"10.1007\/s13346-023-01402-y"},{"key":"3133_CR20","doi-asserted-by":"publisher","unstructured":"Zimmermann CM, Baldassi D, Chan K, Adams NBP, Neumann A, Porras-Gonzalez DL, et al. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery. Journal of Controlled Release. 2022;351:137\u201350. Available from: https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.021.","DOI":"10.1016\/j.jconrel.2022.09.021"},{"key":"3133_CR21","doi-asserted-by":"crossref","unstructured":"Zimmermann CM, De\u00dfloch L, J\u00fcrgens DC, Luciani P, Merkel OM. Evaluation of the effects of storage conditions on spray-dried siRNA-LNPs before and after subsequent drying. European Journal of Pharmaceutics and Biopharmaceutics. 2023;193:218\u201326. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123002965.","DOI":"10.1016\/j.ejpb.2023.11.007"},{"key":"3133_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1080\/07373937.2021.1903032","volume":"39","author":"JT Pinto","year":"2021","unstructured":"Pinto JT, Faulhammer E, Dieplinger J, Dekner M, Makert C, Nieder M, et al. Progress in spray-drying of protein pharmaceuticals: Literature analysis of trends in formulation and process attributes. Drying Technol. 2021;39:1415\u201346.","journal-title":"Drying Technol"},{"key":"3133_CR23","doi-asserted-by":"crossref","unstructured":"Samborska K, Poozesh S, Bara\u0144ska A, Sobulska M, Jedli\u0144ska A, Arpagaus C, et al. Innovations in spray drying process for food and pharma industries. J Food Eng. 2022;321.","DOI":"10.1016\/j.jfoodeng.2022.110960"},{"key":"3133_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.powtec.2012.03.014","volume":"224","author":"S Mandato","year":"2012","unstructured":"Mandato S, Rondet E, Delaplace G, Barkouti A, Galet L, Accart P, et al. Liquids\u2019 atomization with two different nozzles: Modeling of the effects of some processing and formulation conditions by dimensional analysis. Powder Technol. 2012;224:323\u201330.","journal-title":"Powder Technol"},{"key":"3133_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijpharm.2018.09.045","volume":"552","author":"W Liang","year":"2018","unstructured":"Liang W, Chow MYT, Chow SF, Chan HK, Kwok PCL, Lam JKW. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation. Int J Pharm. 2018;552:67\u201375.","journal-title":"Int J Pharm"},{"key":"3133_CR26","doi-asserted-by":"crossref","unstructured":"Anandharamakrishnan C. Handbook of Drying for Dairy Products. Chichester, UK: John Wiley & Sons, Ltd; 2017.","DOI":"10.1002\/9781118930526"},{"key":"3133_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2022.05.002","volume":"176","author":"P Henriques","year":"2022","unstructured":"Henriques P, Fortuna A, Doktorovov\u00e1 S. Spray dried powders for nasal delivery: Process and formulation considerations. Eur J Pharm Biopharm. 2022;176:1\u201320.","journal-title":"Eur J Pharm Biopharm"},{"key":"3133_CR28","doi-asserted-by":"crossref","unstructured":"Begum F, Amin S. Investigating the Influence of Polysorbate 20\/80 and Polaxomer P188 on the Surface & Interfacial Properties of Bovine Serum Albumin and Lysozyme. Pharm Res. 2019;36.","DOI":"10.1007\/s11095-019-2631-6"},{"key":"3133_CR29","doi-asserted-by":"publisher","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharm. 2021;601:120586. Available from: https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120586.","DOI":"10.1016\/j.ijpharm.2021.120586"},{"key":"3133_CR30","doi-asserted-by":"crossref","unstructured":"Mochizuki S, Kanegae N, Nishina K, Kamikawa Y, Koiwai K, Masunaga H, et al. The role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA transfection cooperating with a cationic lipid bearing ethylenediamine. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2013;1828:412\u20138.","DOI":"10.1016\/j.bbamem.2012.10.017"},{"key":"3133_CR31","doi-asserted-by":"crossref","unstructured":"Roces CB, Lou G, Jain N, Abraham S, Thomas A, Halbert GW, et al. Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics. Pharmaceutics. 2020;12:1095. Available from: https:\/\/www.mdpi.com\/1999-4923\/12\/11\/1095.","DOI":"10.3390\/pharmaceutics12111095"},{"key":"3133_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41434-019-0095-2","volume":"26","author":"AK Blakney","year":"2019","unstructured":"Blakney AK, McKay PF, Yus BI, Aldon Y, Shattock RJ. Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA. Gene Ther. 2019;26:363\u201372.","journal-title":"Gene Ther"},{"key":"3133_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharm. 2021;601: 120586.","journal-title":"Int J Pharm"},{"key":"3133_CR34","unstructured":"EMA. Onpattro: Summary of Product Characteristics. 2018. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/onpattro-epar-product-information_en.pdf. Cited 2023 Jan 6."},{"key":"3133_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jconrel.2015.10.024","volume":"220","author":"Y Suzuki","year":"2015","unstructured":"Suzuki Y, Hyodo K, Tanaka Y, Ishihara H. SiRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo. J Control Release. 2015;220:44\u201350.","journal-title":"J Control Release"},{"key":"3133_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jconrel.2009.10.024","volume":"142","author":"C Chen","year":"2010","unstructured":"Chen C, Han D, Cai C, Tang X. An overview of liposome lyophilization and its future potential. J Control Release. 2010;142:299\u2013311.","journal-title":"J Control Release"},{"key":"3133_CR37","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","volume":"58","author":"W Abdelwahed","year":"2006","unstructured":"Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58:1688\u2013713.","journal-title":"Adv Drug Deliv Rev"},{"key":"3133_CR38","first-page":"139","volume":"10","author":"S Franz\u00e9","year":"2018","unstructured":"Franz\u00e9 S, Selmin F, Samaritani E, Minghetti P, Cilurzo F. Lyophilization of Liposomal Formulations: Still Necessary. Still Challenging Pharmaceutics. 2018;10:139.","journal-title":"Still Challenging Pharmaceutics"},{"key":"3133_CR39","doi-asserted-by":"crossref","unstructured":"Crommelin DJA, Anchordoquy TJ, Volkin DB, Jiskoot W, Mastrobattista E. Addressing the Cold Reality of mRNA Vaccine Stability. J Pharm Sci. 2021;110:997\u20131001. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920307851.","DOI":"10.1016\/j.xphs.2020.12.006"},{"key":"3133_CR40","doi-asserted-by":"crossref","unstructured":"Oude Blenke E, \u00d6rnskov E, Sch\u00f6neich C, Nilsson GA, Volkin DB, Mastrobattista E, et al. The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case. J Pharm Sci. 2023;112:386\u2013403. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922005147.","DOI":"10.1016\/j.xphs.2022.11.001"},{"key":"3133_CR41","first-page":"358","volume":"5","author":"P Zhao","year":"2020","unstructured":"Zhao P, Hou X, Yan J, Du S, Xue Y, Li W, et al. Long-term storage of lipid-like nanoparticles for mRNA delivery. Bioact Mater. 2020;5:358\u201363.","journal-title":"Bioact Mater"},{"key":"3133_CR42","doi-asserted-by":"publisher","unstructured":"Costa C, Nobre B, Matos AS, Silva AS, Casimiro T, Corvo ML, et al. Inhalable hydrophilic molecule-loaded liposomal dry powder formulations using supercritical CO2 \u2013 assisted spray-drying. Journal of CO2 Utilization. 2021;53:101709. Available from: https:\/\/doi.org\/10.1016\/j.jcou.2021.101709.","DOI":"10.1016\/j.jcou.2021.101709"},{"key":"3133_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcis.2020.05.045","volume":"577","author":"J An","year":"2020","unstructured":"An J, Forchheimer D, S\u00e4vmarker J, Br\u00fclls M, Frenning G. Nanoscale characterization of PEGylated phospholipid coatings formed by spray drying on silica microparticles. J Colloid Interface Sci. 2020;577:92\u2013100.","journal-title":"J Colloid Interface Sci"},{"key":"3133_CR44","first-page":"24","volume":"40","author":"A Siew","year":"2016","unstructured":"Siew A. Exploring the use of aseptic spray drying in the manufacture of biopharmaceutical injectables. Pharm Technol. 2016;40:24\u20137.","journal-title":"Pharm Technol"},{"key":"3133_CR45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ijbiomac.2016.10.087","volume":"95","author":"B Wang","year":"2017","unstructured":"Wang B, Timilsena YP, Blanch E, Adhikari B. Characteristics of bovine lactoferrin powders produced through spray and freeze drying processes. Int J Biol Macromol. 2017;95:985\u201394.","journal-title":"Int J Biol Macromol"},{"key":"3133_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","volume":"154\u2013155","author":"E Samaridou","year":"2020","unstructured":"Samaridou E, Heyes J, Lutwyche P. Lipid nanoparticles for nucleic acid delivery: Current perspectives. Adv Drug Deliv Rev. 2020;154\u2013155:37\u201363.","journal-title":"Adv Drug Deliv Rev"},{"key":"3133_CR47","doi-asserted-by":"crossref","unstructured":"Chavan T, Muttil P, Kunda NK. Introduction to Nanomedicine in Drug Delivery. AAPS Advances in the Pharmaceutical Sciences Series. 2020.","DOI":"10.1007\/978-3-030-35910-2_1"},{"key":"3133_CR48","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jddst.2018.06.011","volume":"46","author":"C Yue-Xing","year":"2018","unstructured":"Yue-Xing C, Fei-Fei Y, Han W, Tao-Tao F, Chun-Yu L, Li-Hui Q, et al. The effect of l -leucine on the stabilization and inhalability of spray-dried solid lipid nanoparticles for pulmonary drug delivery. J Drug Deliv Sci Technol. 2018;46:474\u201381.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3133_CR49","first-page":"305","volume":"12","author":"R Lball","year":"2017","unstructured":"Lball R, Bajaj P, Whitehead KA. Achieving long-term stability of lipid nanoparticles: Examining the effect of pH, temperature, and lyophilization. Int J Nanomedicine. 2017;12:305\u201315.","journal-title":"Int J Nanomedicine"},{"key":"3133_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jconrel.2015.02.026","volume":"203","author":"W Zhang","year":"2015","unstructured":"Zhang W, Wang G, See E, Shaw JP, Baguley BC, Liu J, et al. Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation. J Control Release. 2015;203:161\u20139.","journal-title":"J Control Release"},{"key":"3133_CR51","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0006-3495(02)75499-4","volume":"82","author":"SA Maskarinec","year":"2002","unstructured":"Maskarinec SA, Hannig J, Lee RC, Lee KYC. Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys J. 2002;82:1453\u20139.","journal-title":"Biophys J"},{"key":"3133_CR52","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1021\/acs.jpcb.5b11448","volume":"120","author":"U Adhikari","year":"2016","unstructured":"Adhikari U, Goliaei A, Tsereteli L, Berkowitz ML. Properties of poloxamer molecules and poloxamer micelles dissolved in water and next to lipid bilayers: Results from computer simulations. J Phys Chem B. 2016;120:5823\u201330.","journal-title":"J Phys Chem B"},{"key":"3133_CR53","doi-asserted-by":"crossref","unstructured":"Trenkenschuh E, Richter M, Heinrich E, Koch M, Fuhrmann G, Friess W. Enhancing the Stabilization Potential of Lyophilization for Extracellular Vesicles. Adv Healthc Mater. 2022;11.","DOI":"10.1002\/adhm.202100538"},{"key":"3133_CR54","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bpj.2011.12.029","volume":"102","author":"M Nazari","year":"2012","unstructured":"Nazari M, Kurdi M, Heerklotz H. Classifying surfactants with respect to their effect on lipid membrane order. Biophys J. 2012;102:498\u2013506.","journal-title":"Biophys J"},{"key":"3133_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel S, Ashwanikumar N, Robinson E, Xia Y, Mihai C, Griffith JP, et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat Commun. 2020;11:1\u201313.","journal-title":"Nat Commun"},{"key":"3133_CR56","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/mt.2011.56","volume":"19","author":"RC Adami","year":"2011","unstructured":"Adami RC, Seth S, Harvie P, Johns R, Fam R, Fosnaugh K, et al. An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA. Mol Ther. 2011;19:1141\u201351.","journal-title":"Mol Ther"},{"key":"3133_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122171","volume":"626","author":"A Lokras","year":"2022","unstructured":"Lokras A, Chakravarty A, Rades T, Christensen D, Franzyk H, Thakur A, et al. Simultaneous quantification of multiple RNA cargos co-loaded into nanoparticle-based delivery systems. Int J Pharm. 2022;626: 122171.","journal-title":"Int J Pharm"},{"key":"3133_CR58","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jiec.2016.11.032","volume":"47","author":"D \u0106irin","year":"2017","unstructured":"\u0106irin D, Krstono\u0161i\u0107 V, Po\u0161a M. Properties of poloxamer 407 and polysorbate mixed micelles: Influence of polysorbate hydrophobic chain. J Ind Eng Chem. 2017;47:194\u2013201.","journal-title":"J Ind Eng Chem"},{"key":"3133_CR59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","volume":"353","author":"B Kim","year":"2023","unstructured":"Kim B, Hosn RR, Remba T, Yun D, Li N, Abraham W, et al. Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines. J Control Release. 2023;353:241\u201353.","journal-title":"J Control Release"},{"key":"3133_CR60","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1529\/biophysj.106.096461","volume":"92","author":"G van den Bogaart","year":"2007","unstructured":"van den Bogaart G, Hermans N, Krasnikov V, de Vries AH, Poolman B. On the Decrease in Lateral Mobility of Phospholipids by Sugars. Biophys J. 2007;92:1598\u2013605.","journal-title":"Biophys J"},{"key":"3133_CR61","doi-asserted-by":"crossref","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28\u201351. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X15002173.","DOI":"10.1016\/j.addr.2015.09.012"},{"key":"3133_CR62","doi-asserted-by":"crossref","unstructured":"Cheng F, Wang Y, Bai Y, Liang Z, Mao Q, Liu D, et al. Research Advances on the Stability of mRNA Vaccines. Viruses. 2023;15:668. Available from: https:\/\/www.mdpi.com\/1999-4915\/15\/3\/668.","DOI":"10.3390\/v15030668"},{"key":"3133_CR63","doi-asserted-by":"crossref","unstructured":"Tenchov R, Sasso JM, Zhou QA. PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective. Bioconjug Chem. 2023;34:941\u201360. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acs.bioconjchem.3c00174\n.","DOI":"10.1021\/acs.bioconjchem.3c00174"},{"key":"3133_CR64","doi-asserted-by":"crossref","unstructured":"Fang Y, Xue J, Gao S, Lu A, Yang D, Jiang H, et al. Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery. Drug Deliv. 2017;24:22\u201332. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10717544.2017.1388451\n.","DOI":"10.1080\/10717544.2017.1388451"},{"key":"3133_CR65","doi-asserted-by":"crossref","unstructured":"Zhang H, Leal J, Soto MR, Smyth HDC, Ghosh D. Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments. Pharmaceutics. 2020;12:1\u201316. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33143328\/.","DOI":"10.3390\/pharmaceutics12111042"},{"key":"3133_CR66","doi-asserted-by":"publisher","unstructured":"Lokugamage MP, Vanover D, Beyersdorf J, Hatit MZC, Rotolo L, Echeverri ES, et al. Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs. Nat Biomed Eng. 2021;5:1059\u201368. Available from: https:\/\/doi.org\/10.1038\/s41551-021-00786-x.","DOI":"10.1038\/s41551-021-00786-x"},{"key":"3133_CR67","doi-asserted-by":"crossref","unstructured":"Scioli Montoto S, Muraca G, Ruiz ME. Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects. Front Mol Biosci. 2020;7:1\u201324. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.587997\/full\n.","DOI":"10.3389\/fmolb.2020.587997"},{"key":"3133_CR68","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.omtn.2022.09.017","volume":"30","author":"Y Suzuki","year":"2022","unstructured":"Suzuki Y, Miyazaki T, Muto H, Kubara K, Mukai Y, Watari R, et al. Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates. Mol Ther Nucleic Acids. 2022;30:226\u201340.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3133_CR69","doi-asserted-by":"crossref","unstructured":"Ingvarsson PT, Yang M, Nielsen HM\u00f8, Rantanen J, Foged C. Stabilization of liposomes during drying. Expert Opin Drug Deliv. 2011;8:375\u201388.","DOI":"10.1517\/17425247.2011.553219"},{"key":"3133_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2019.00424","volume":"7","author":"D Guimar\u00e3es","year":"2019","unstructured":"Guimar\u00e3es D, Noro J, Silva C, Cavaco-Paulo A, Nogueira E. Protective Effect of Saccharides on Freeze-Dried Liposomes Encapsulating Drugs. Front Bioeng Biotechnol. 2019;7:1\u20138.","journal-title":"Front Bioeng Biotechnol"},{"key":"3133_CR71","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejpb.2021.10.014","volume":"169","author":"W Luo","year":"2021","unstructured":"Luo W, O\u2019Reilly Beringhs A, Kim R, Zhang W, Patel SM, Bogner RH, et al. Impact of formulation on the quality and stability of freeze-dried nanoparticles. Eur J Pharm Biopharm. 2021;169:256\u201367.","journal-title":"Eur J Pharm Biopharm"},{"key":"3133_CR72","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3109\/02652048.2012.686530","volume":"29","author":"RT De Paula","year":"2012","unstructured":"De Paula RT, Silva CL, Santana MHA, Rosada RS, De La Torre LG. Effects of extrusion, lipid concentration and purity on physico-chemical and biological properties of cationic liposomes for gene vaccine applications. J Microencapsul. 2012;29:759\u201369.","journal-title":"J Microencapsul"},{"key":"3133_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbamem.2005.05.001","volume":"1713","author":"S Ohtake","year":"2005","unstructured":"Ohtake S, Schebor C, Palecek SP, De Pablo JJ. Phase behavior of freeze-dried phospholipid-cholesterol mixtures stabilized with trehalose. Biochim Biophys Acta Biomembr. 2005;1713:57\u201364.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"3133_CR74","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.xphs.2019.10.055","volume":"109","author":"T Starciuc","year":"2020","unstructured":"Starciuc T, Malfait B, Danede F, Paccou L, Guinet Y, Correia NT, et al. Trehalose or Sucrose: Which of the Two Should be Used for Stabilizing Proteins in the Solid State? A Dilemma Investigated by In Situ Micro-Raman and Dielectric Relaxation Spectroscopies During and After Freeze-Drying. J Pharm Sci. 2020;109:496\u2013504.","journal-title":"J Pharm Sci"},{"key":"3133_CR75","doi-asserted-by":"crossref","unstructured":"Fan Y, Rigas D, Kim LJ, Chang F-P, Zang N, McKee K, et al. Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings. Journal of Controlled Release. 2024;373:727\u201337. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924005078.","DOI":"10.1016\/j.jconrel.2024.07.052"},{"key":"3133_CR76","doi-asserted-by":"crossref","unstructured":"Alejo T, Toro-C\u00f3rdova A, Fern\u00e1ndez L, Rivero A, Stoian AM, P\u00e9rez L, et al. Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs. Int J Mol Sci. 2024;25:10603. Available from: https:\/\/www.mdpi.com\/1422-0067\/25\/19\/10603.","DOI":"10.3390\/ijms251910603"},{"key":"3133_CR77","doi-asserted-by":"crossref","unstructured":"Ogawa K, Aikawa O, Tagami T, Ito T, Tahara K, Kawakami S, et al. Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying. Int J Pharm. 2024;665:124632. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517324008664.","DOI":"10.1016\/j.ijpharm.2024.124632"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03133-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T16:47:01Z","timestamp":1751906821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03133-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":77,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3133"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03133-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflicts on interest.AI technology was used to assist in improving the text of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"145"}}